ArticleBioinformatics (Oxford, England)2026
Multiscale higher-order molecular simplicial complex embedding for drug response prediction.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationAccurately predicting anticancer drug response is a central challenge in precision oncology. Existing computational methods, although valuable, often depend on pairwise molecular descriptors or limited graph-based encodings that cannot fully capture the complexity of molecular structures or their interactions with cellular states. These constraints hinder their robustness and generalization across diverse drugs and biological contexts, underscoring the need for more expressive frameworks.
resultsTo address this gap, we propose MolDr, a topological deep learning framework that represents molecules as multiscale simplicial complexes and propagates information across higher-order structures. By integrating these molecular representations with cellular profiles, MolDr unifies chemical topology and biological context within a single predictive model. Comprehensive experiments show that MolDr consistently outperforms or matches state-of-the-art baselines across multiple benchmarks. It achieves stronger accuracy and robustness on continuous drug response tasks, while also generalizing effectively to discrete classification settings. Moreover, sensitivity analysis confirms the benefit of incorporating multiple topological scales, further supporting the importance of higher-order representations. Together, these results demonstrate that MolDr delivers reliable performance across heterogeneous pharmacogenomic scenarios and highlight the promise of topological modeling for advancing drug response prediction. AVAILABILITY: Source code freely available at https://github.com/CS-BIO/MolDr.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.